Moreover, studies show that the PI3K pathway is a crucial sensor of genomic integrity and the PI3K downstream gene AKT is activated when exposed to PARP inhibitors, and these changes limit the efficacy of PARP inhibitors in the treatment of cancers. Here, PARP1 is linked to cancer.